Cardiac resynchronization therapy in the intensive care setting; the promise and peril of using implantable devices off label

European Journal of Heart Failure

Volumn 10, Issue 3, 2008, Pages 220-221

  Braunschweig, Frieder ^a   Hauptman, Paul J ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

CARDIAC RESYNCHRONIZATION THERAPY; CRITICAL ILLNESS; DEVICE; DISEASE SEVERITY; EDITORIAL; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INOTROPISM; INTENSIVE CARE; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; SURVIVAL;

CARDIAC PACING, ARTIFICIAL; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; INTENSIVE CARE UNITS; PACEMAKER, ARTIFICIAL; PRODUCT LABELING; VENTRICULAR DYSFUNCTION, LEFT;

EID: 40249089743     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.02.001     Document Type: Editorial

References (12)

1. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 24 (2002) 1845-1853
2. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 15 (2005 Apr 14) 1539-1549
3. Freemantle N., Tharmanathan P., Calvert M.J., Abraham W.T., Ghosh J., and Cleland J.G. Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction-a systematic review and meta-analysis. Eur J Heart Fail 8 4 (2006 Jun) 433-440
4. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 11 (2005 Jun) 1115-1140
5. Auricchio A., Stellbrink C., Block M., et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. Circulation 99 23 (1999) 2993-3001
6. Kass D.A., Chen C.H., Curry C., et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 99 12 (1999) 1567-1573
7. Milliez P., Thomas O., Haggui A., et al. Cardiac resynchronisation as a rescue therapy in patients with catecholamine dependent overt heart failure: results from a short and mid-term study. Eur J Heart Fail 10 (2008) 291-297 (this issue)
8. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
9. Cowburn P.J., Patel H., Jolliffe R.E., Wald R.W., and Parker J.D. Cardiac resynchronisation therapy: an option for inotrope-supported patients with end-stage heart failure?. Eur J Heart Fail 7 2 (2005) 215-217 2005/3/2
10. Konstantino Y., Iakobishvili Z., Arad O., et al. Urgent cardiac resynchronization therapy in patients with decompensated chronic heart failure receiving inotropic therapy. A case series. Cardiology 106 1 (2006) 59-62
11. James K.B., Militello M., Barbara G., and Wilkoff B.L. Biventricular pacing for heart failure patients on inotropic support: a review of 38 consecutive cases. Tex Heart Inst J 33 1 (2006) 19-22
12. Cleland J.G., Freemantle N., Coletta A.P., and Clark A.L. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail. 8 1 (2006 Jan) 105-110